On June 23, 2021, Lyndra Therapeutics, Inc. closed the transaction. The company received $60,500,000 in the round led by new investor AIG Investments, Ltd. The transaction included participation from new investors Yipinhong Pharmaceutical (USA) Limited, Limitless Earth plc, and The Catalytic Impact Foundation, Inc. through ImpactAssets and returning investors Polaris Partners, The Invus Group, LLC, Quark Venture Inc., Partners Innovation Management Co., LLC, HOPU Jinghua (Beijing) Investment Consultancy Co., Ltd., and Gilead Sciences, Inc. The company received $60,470,112 pursuant to exemption provided under Regulation D from 22 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 GBX | 0.00% | -28.89% | -28.89% |
2023 | Limitless Earth half-year loss stretches | AN |
2023 | Limitless Earth plc Reports Earnings Results for the Half Year Ended July 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.89% | 1.38M | |
-5.90% | 114B | |
-5.79% | 87.22B | |
+9.71% | 64.53B | |
+20.26% | 62.28B | |
+9.51% | 42.63B | |
+10.30% | 41.73B | |
+19.41% | 34.99B | |
+3.54% | 24.9B | |
-3.96% | 22.41B |
- Stock Market
- Equities
- LME Stock
- News Limitless Earth plc
- Lyndra Therapeutics, Inc. announced that it has received $60.5 million in funding from a group of investors